FYR Diagnostics
FYR is a precision medicine company leveraging its proprietary EV-Omics (EVO) platform, which utilizes SPARCs technology to enrich extracellular vesicles (EVs) from blood. This allows for the assessment of proteins and nucleic acids to decode RNA and protein signals, providing deeper insights into disease mechanisms and progression. Their AI-enabled multiomic approach aims to transform personalized patient care by enabling dynamic observation of disease from screening through therapy selection and monitoring. FYR partners with entities in drug development, diagnostics, and precision medicine to accelerate innovation, supporting goals from discovery through clinical validation with tailored study designs and flexible engagement models.
FYR Diagnostics
FYR is a precision medicine company leveraging its proprietary EV-Omics (EVO) platform, which utilizes SPARCs technology to enrich extracellular vesicles (EVs) from blood. This allows for the assessment of proteins and nucleic acids to decode RNA and protein signals, providing deeper insights into disease mechanisms and progression. Their AI-enabled multiomic approach aims to transform personalized patient care by enabling dynamic observation of disease from screening through therapy selection and monitoring. FYR partners with entities in drug development, diagnostics, and precision medicine to accelerate innovation, supporting goals from discovery through clinical validation with tailored study designs and flexible engagement models.